Evidence map›Paper›PMID 33409794›Full record

Observational studyEuropean radiology2021

The impact of bronchial artery embolisation on the quality of life of patients with haemoptysis: a prospective observational study.

Naoki Omachi, Hideo Ishikawa, Masahiko Hara, Takashi Nishihara, Yu Yamaguchi, Yumiko Yamamoto, Mihoko Youmoto, Tomoaki Hattori, Kazushi Kitaguchi, Shota Yamamoto and 2 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Naoki OmachiHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan. oooomachi@gmail.com.ORCID http://orcid.org/0000-0001-5414-1157
Hideo IshikawaHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Masahiko HaraCenter for Community-Based Healthcare Research and Education, Shimane University Graduate School of Medicine, Izumo, Japan.
Takashi NishiharaHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Yu YamaguchiHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Yumiko YamamotoHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Mihoko YoumotoHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Tomoaki HattoriHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Kazushi KitaguchiHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Shota YamamotoHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Tomoya KawaguchiDepartment of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Masahiro FukuzawaHemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, Kamimatsu-Chou 2-8-10, Kishiwada, Osaka, 596-0827, Japan.
Kishiwada City Hospital · JPOsaka City University · JPShimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPatients with haemoptysis often experience daily physical and mental impairment. Bronchial artery embolisation is among the first-line treatment options used worldwide; however, no evidence exists regarding the health-related quality of life (HRQoL) after bronchial artery embolisation. Therefore, this study aimed to evaluate the effects of bronchial artery embolisation on the HRQoL of patients with haemoptysis.

methodsWe prospectively enrolled 61 consecutive patients who visited our hospital from July 2017 to August 2018 and received bronchial artery embolisation for haemoptysis. The primary outcome was the HRQoL evaluated using the Short Form Health Survey, which contains physical and mental components, before and after bronchial artery embolisation. The secondary outcomes were procedural success, complications, and recurrence-free survival rate at 6 months.

resultsThe mean age of the patients was 69 years (range, 31-87 years). The procedural success rate was 98%. No major complications occurred. The recurrence-free survival rate estimated using the Kaplan-Meier analysis at 6 months after bronchial artery embolisation was 91.8% (95% confidence interval, 91.1-92.5%). Compared with the pre-treatment scores, the physical and mental scores were significantly improved at 6 months after bronchial artery embolisation (p < 0.05).

conclusionBronchial artery embolisation improved the HRQoL of patients with haemoptysis. KEY POINTS: • Bronchial artery embolisation improved the HRQoL of patients with haemoptysis. • Vessel dilation on computed tomography and systemic artery-pulmonary artery direct shunting on angiography were the most common abnormalities. • The recurrence-free survival rate estimated using the Kaplan-Meier analysis at 6 months after bronchial artery embolisation was 91.8%.

Indexed as

Embolization, TherapeuticQuality of LifeAdultAgedAged, 80 and overBronchial ArteriesHemoptysisHumansMiddle AgedRetrospective StudiesTreatment OutcomeBronchial arteryEmbolisationHaemoptysisQuality of life

Identifiers

PMID33409794
PMCPMC8213576
OpenAlexW3119910275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.